AI Assistant
Blog
Pricing
Log In
Sign Up
Use of anti-GD2 (Dinutuximab) as a target for CAR-T cells immunotherapy in neuroblastoma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
